Afatinib/Osimertinib Treatment Combinations in EGFR-Mutated Advanced NSCLC
As part of a Satellite Sessions program focused on the Cleveland Clinic and surrounding institutions, CancerNetwork hosted a panel discussion on treatment options for patients with EGFR-mutated non–small cell lung cancer (NSCLC). The program was brought …